SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality
Andrew Bryan, Susan L. Fink, Meghan A. Gattuso, Gregory Pepper, Anu Chaudhary, Mark H. Wener, Chihiro Morishima, Keith R. Jerome, Patrick C. Mathias, Alexander L. Greninger
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load on admission was associated with a significantly increased 30-day mortality (odds ratio [OR], 4.20; 95% CI, 1.62-10.86), and anti-SARS-CoV-2 nucleocapisid IgG seropositivity on admission trended toward a reduced 30-day mortality (OR, 0.43; 95% CI, 0.15-1.26). Reporting of quantitative SARS-CoV-2 viral load and serologic assays may offer prognostic clinical information.
Topics & Concepts
MedicineViral loadCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyInternal medicineVirusOutbreakDiseaseInfectious disease (medical specialty)COVID-19 epidemiological studiesCOVID-19 Clinical Research StudiesCOVID-19 and Mental Health